Nachrichten zur Veru Aktie

Veru mulls selling female health business

Shares of Veru Inc. gained 6.5% in trading on Monday after the company said it is considering selling its…

Veru exploring alternatives for female health business

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Veru Exploring Strategic Alternatives for its Legacy Female Health Business

MIAMI, March 08, 2021 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus…

Veru to Participate in Fireside Chat at the H.C. Wainwright Global Life Sciences Conference

MIAMI, March 02, 2021 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus…

Veru (VERU) Reports Q1 Loss, Tops Revenue Estimates (Revised)

Veru (VERU) delivered earnings and revenue surprises of 50.00% and 37.56%, respectively, for the quarter ended December 2020. Do the…

Veru shares jump 10% as company gets FDA OK to advance COVID-19 candidate

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Veru Files US Application For TADFIN Combo For Prostate Enlargement

Veru submits TADFIN new drug application for benign prostatic hyperplasia

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Veru, Invitae And More Are Moving Today

Community Health Systems (NYSE: CYH) shares are trading higher after the company reported better-than-expected fourth-quarter sales results. read more...…

Veru Raises $100M Via Equity At 10% Discount

Veru secures $100M via equity offering

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Veru Announces Pricing of Public Offering of Common Stock

MIAMI, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus…

Veru Announces Proposed Public Offering of Common Stock

MIAMI, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus…

VERU INC.: 10-Q Report

10-Q...…

Thinking about trading options or stock in Moderna, Tilray, Lyft, Under Armour, or Veru?

NEW YORK , Feb. 10, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MRNA,…

Female Health Company The (VERU) Reports Q1 Loss, Tops Revenue Estimates

Female Health Company The (VERU) delivered earnings and revenue surprises of 50.00% and 37.56%, respectively, for the quarter ended December…

Veru EPS in-line, beats on revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Veru Sets Another Quarterly Record in Both Net Revenues and in Gross Profit for Fiscal 2021 First Quarter

--Q1 FY21 Net Revenues and Gross Profit of $15M and $11M, Respectively, Achieve New Historical Highs for Second Consecutive Quarter--…

Why Veru Stock Surged Today

Analysts are excited about the potential of the biotechs experimental COVID-19 treatment....…

Veru Leaps on Progress With COVID-19 Treatment Trial

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

Veru CEO says cancer drug has potential to prevent Covid-19 deaths

Veru CEO Dr. Mitchell Steiner explained how VERU-111, a prostate cancer drug developed by the biotech company, could be used…

Veru CEO discusses clinical results of prostate cancer drug being studied to treat Covid-19

Veru CEO Dr. Mitchell Steiner joined Jim Cramer on "Mad Money" to break down findings from a Phase 2 clinical…

Why Veru Stock Is Skyrocketing Today

The company reported great results from a phase 2 study in treating hospitalized COVID-19 patients....…

Thinking about buying stock in Ocugen, Westport Fuel Systems, Purple Biotech, TherapeuticsMD, or Veru?

NEW YORK , Feb. 8, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for…

Veru posts positive phase 2 study results of VERU-111 in hospitalized COVID-19 patients

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Veru Reports Positive Phase 2 Clinical Results of VERU-111 in Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome

– Potential for two-pronged action against COVID-19 as an antiviral and anti-inflammatory agent supported by…

T2 Biosystems, Zomedica leads healthcare gainers; Pro-Dex, Veru among major losers

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Veru to Report Fiscal 2021 First-Quarter Financial Results, Host Conference Call on February 10th

MIAMI, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus…

Is The Rally In Veru Overdone?

After a stellar 3x rise since the March 23 levels of last year, at the current price of around $10…

Veru to Present at the H.C. Wainwright Bioconnect 2021 Conference on January 11th, 2021

MIAMI, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus…

Veru Inc.: Robust Oncology Drug Pipeline Driving Bullish Momentum

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Veru stock price target raised to $19 from $9 at Oppenheimer

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

Implied Volatility Surging for Veru (VERU) Stock Options

Investors need to pay close attention to Veru (VERU) stock based on the movements in the options market lately....…

Thinking about buying stock in Anavex Life Sciences, Veru Inc, vTv Therapeutics, BioCardia, or 22nd Century Group?

NEW YORK , Dec. 15, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for…

Veru CEO on developing drug prostate cancer and breast cancer

Veru CEO Michael Steiner joined Jim Cramer on "Mad Money" to discuss data behind the oncology biopharmaceutical company's study of…

Thinking about buying stock in Pfizer, Moderna, Arvinas, Veru, or Alexion Pharmaceuticals?

NEW YORK , Dec. 14, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PFE,…

Veru Reports Positive Phase 2 Clinical Trial Results for Enobosarm, Selective Androgen Receptor Targeting Agent, for Endocrine Resistant Metastatic Breast Cancer

-- Phase 2 Multicenter, International Clinical Study Selected as Spotlight Presentation at 2020 San Antonio Breast Cancer Symposium –...…

VERU-111, Cytoskeleton Disruptor, Demonstrates Efficacy in Preclinical Models of Human Triple Negative Breast Cancer

-- Preclinical Data Presented at the 2020 San Antonio Breast Cancer Symposium-- -- VERU-111 has Anticancer Activity in Both Paclitaxel…

Veru soars as HC Wainwright sees value from enobosarm addition

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

VERU INC.: 10-K Report

10-K...…

Thinking about buying stock in Pfizer, Rewalk Robotics, Veru, Arbutus Biopharma, or Plug Power?

NEW YORK , Dec. 10, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PFE,…

Veru Inc. (VERU) Q4 2020 Earnings Call Transcript

VERU earnings call for the period ending September 30, 2020....…

Veru, Inc. (VERU) CEO Mitchell Steiner on Q4 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Veru in-licenses late-stage androgen receptor targeted therapy for breast cancer

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Recap: Veru Q4 Earnings

Shares of Veru (NASDAQ:VERU) moved higher by 4.2% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share…

Veru Expands Oncology Drug Pipeline; Exclusively Licenses Phase 3 Clinical Stage Targeted Therapy for Endocrine Resistant Metastatic Breast Cancer

--Transformation to Premium Oncology Biopharmaceutical Company with Late-Stage Clinical Drug Pipeline Focused on Prostate and Breast Cancer is Complete-- --Company…